GreyBird Ventures
Overview
An early stage venture capital firm we invest in companies with technology for precision medicine diagnosis. The technologies in focus have the characteristics of very high specificity and the capability to dramatically improve the choice of optimum therapy and reduce cost. Our companies will have a well-protected IP position and management with deep domain knowledge and a sense of creative thrift. Founded by Michael Devlin and Tom Miller, we are in the early stages of fund-raising but already have investments in prototypical portfolio companies. We have also recruited a team of eight operating advisors located in North America, Europe, and Asia with extremely deep domain expertise and operating experience.
Reach GreyBird Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about GreyBird Ventures
What sectors does GreyBird Ventures invest in?
GreyBird Ventures invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Research, and is based in Concord, Massachusetts, United States. GreyBird Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does GreyBird Ventures invest at?
GreyBird Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does GreyBird Ventures invest in?
GreyBird Ventures invests across United States.
Who are the partners at GreyBird Ventures?
Team members listed for GreyBird Ventures include Tom Miller (Founder) and Michael Devlin (Founder).
How do I contact GreyBird Ventures?
GreyBird Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
